Cortisone Acetate

醋酸可的松

Report date: 2023/10/25 15:45:28
NME

Base Information

Drug NameCortisone Acetate
Drug Alias Namecortisona有醋酸可的松乙酸可的松cortisonum醋酸考的松 +[13] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsInflammationHypersensitivityHypoadrenocorticism, Familial +[30] 
Global Approved IndicationsInflammationHypersensitivityHypoadrenocorticism, Familial +[30] 
Approved Indications in ChinaHypoadrenocorticism, FamilialAdrenal Gland DiseasesConjunctivitis
Original Approved Country/TerritoryUnited States
Original Approved Date1950/06/13
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesNichi-Iko Pharmaceutical Co LtdChengdu First Pharmaceutical Co LtdWuhan Wujing Pharmaceutical Co Ltd
Inactive CompaniesMerck & Co Inc
Active IndicationsHypoadrenocorticism, FamilialAdrenal Gland DiseasesHypoglycemia +[26] 
Inactive IndicationsInflammationHypersensitivityEye Diseases +[4] 

Other Information

ATC CodeH02AB10S01BA03
Related LinksWikipediaDrugBankKEGG